Clinical Trials Browser

OTHER × Prostatic Neoplasms × rucaparib × Clear all

NCT03533946 2024-03-13

ROAR

Phase 2 Terminated

7 enrolled 10 charts

Prostatic Neoplasms

NCT03572478 2021-03-09

Rucaparib and Nivolumab in Patients With Prostate or Endometrial Cancer

Phase 1/2 Terminated

12 enrolled 7 charts

GenitourinaryGynecologic

Prostatic Neoplasms, Endometrial Neoplasms